EUS-guided Celiac Plexus Block vs. Sham in Chronic Pancreatitis
RecruitingNot applicableNCT06178315
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The aim of this randomized trial is to assess the efficacy of EUS-CPB in the alleviation of abdominal pain in patients with chronic pancreatitis.
Study details
- Official title
- Randomized Trial of EUS-guided Celiac Plexus Block vs. Sham for Palliation of Pain in Chronic Pancreatitis
- Conditions
- Interventions
- Procedure: EUS-guided celiac plexus block
- Procedure: Sham procedure
- Sponsor
- Orlando Health, Inc.
- Start date
- 2023-12-07
- Primary completion
- 2025-12-31
- Sex
- All
- Age range
- from 18 Years
- Results posted
- No results posted in this snapshot
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Age ≥ 18 years * Abdominal pain of at least 3 months duration and a VAS score ≥ 3, with or without the use of narcotic analgesics. * Diagnosis of chronic pancreatitis on EUS examination, with ≥ 5 features on EUS. * No other cause of abdominal pain Exclusion Criteria: * Age \< 18 years. * History of prior EUS-CPB. * Use of anticoagulants that cannot be discontinued for the procedure. * Clinically significant allergy to bupivacaine or triamcinolone. * Unable to obtain consent for the procedure from either the patient or LAR. * Intrauterine pregnancy.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT06178315